Beating Heart Versus Arrested Heart for Isolated Tricuspid Valve Surgery: A Kaplan–Meier–Derived Meta-Analysis
Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery · 2025-09 · 20 (5) · 442-451
DOI: 10.1177/15569845251375959 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery, online erschienen am 17.09.2025. Verfasst von Massimo Baudo und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiac Surgery Research, Lankenau Institute for Medical Research, Main Line Health, Wynnewood, PA, USA. Hauptthemen laut MEDLINE: Tricuspid Valve, Tricuspid Valve Insufficiency, Heart Arrest, Induced. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben.
Abstract (Originalsprache)
Objective
The aim of the current study was to analyze the clinical and surgical outcomes of patients undergoing isolated tricuspid valve surgery (ITVS) from the available literature. It currently remains uncertain whether arrested heart (AH) surgery has superior postoperative outcomes over beating heart (BH) for ITVS.
Methods
A systematic review and meta-analysis were conducted by searching PubMed, ScienceDirect, Scopus, DOAJ, SciELO, and Cochrane databases from 2000 until November 2024. The protocol was registered with the International Prospective Register of Systematic Reviews under the PROSPERO registration number CRD42024622618.
Results
A total of 22 studies met the inclusion criteria. These studies were published between 2012 and 2023 and included a combined total of 1,627 patients, with 1,053 in the BH group and 574 in the AH group. The present analysis showed that patients undergoing BH surgery were generally more comorbid and more frequently underwent minimally invasive procedures as compared with patients undergoing AH surgery. The BH and AH groups reported no significant differences in postoperative outcomes. At follow-up, BH was associated with higher recurrent >2+ tricuspid regurgitation rates ( P = 0.048), but this did not affect late survival (hazard ratio [HR] = 0.90, 95% confidence interval [CI]: 0.68 to 1.19, P = 0.457) or reintervention for TV (HR = 1.18, 95% CI: 0.61 to 2.29, P = 0.622) rates.
Conclusions
A consensus between BH and AH for ITVS is still lacking. However, BH ITVS procedures appear to be the preferred surgeon choice for higher-risk patients. At follow-up, the BH group showed higher rates of recurrent tricuspid regurgitation >2+, without affecting late survival or rates of TV reintervention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiac Surgery Research, Lankenau Institute for Medical Research, Main Line Health, Wynnewood, PA, USA.
- Department of Cardiac Surgery, Lankenau Heart Institute, Main Line Health, Wynnewood, PA, USA.
ORCID-Profile: Massimo Baudo, Serge Sicouri, Yoshiyuki Yamashita, Dimitrios Magouliotis, Francesco Cabrucci
Zitieren
APA
Baudo, M., Sicouri, S., Yamashita, Y., Magouliotis, D., Cabrucci, F., & Ramlawi, B. (2025). Beating Heart Versus Arrested Heart for Isolated Tricuspid Valve Surgery: A Kaplan–Meier–Derived Meta-Analysis. Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery, 20(5), 442-451. https://doi.org/10.1177/15569845251375959
Vancouver
Baudo M, Sicouri S, Yamashita Y, Magouliotis D, Cabrucci F, Ramlawi B. Beating Heart Versus Arrested Heart for Isolated Tricuspid Valve Surgery: A Kaplan–Meier–Derived Meta-Analysis. Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery. 2025;20(5):442-451. doi:10.1177/15569845251375959
BibTeX
@article{Baudo2025,
author = {Baudo, Massimo and Sicouri, Serge and Yamashita, Yoshiyuki and Magouliotis, Dimitrios and Cabrucci, Francesco and Ramlawi, Basel},
title = {Beating Heart Versus Arrested Heart for Isolated Tricuspid Valve Surgery: A Kaplan–Meier–Derived Meta-Analysis},
journal = {Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery},
year = {2025},
volume = {20},
number = {5},
pages = {442--451},
doi = {10.1177/15569845251375959}
}
EUVIMED